Re: Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study
Source: BMJ Comments - Category: General Medicine Source Type: forums
More News: Canagliflozin | Cardiology | Cardiovascular | General Medicine | Heart | Invokana | Study